WILLIAM B DAVISS

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. doi request reprint Associations of lifetime depression with trauma exposure, other environmental adversities, and impairment in adolescents with ADHD
    W Burleson Daviss
    Department of Psychiatry, University of Texas Health Science Center of San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Abnorm Child Psychol 37:857-71. 2009
  2. ncbi request reprint Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects
    W Burleson Daviss
    Western Psychiatric Institute and Clinic and the University of Pittsburgh, USA
    J Child Psychol Psychiatry 47:927-34. 2006
  3. ncbi request reprint Steady-state clinical pharmacokinetics of bupropion extended-release in youths
    W Burleson Daviss
    Western Psychiatric Institute and Clinic, University of Pittsburgh, USA
    J Am Acad Child Adolesc Psychiatry 45:1503-9. 2006
  4. pmc A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment
    W Burleson Daviss
    Deparment of Psychiatry, University of Texas Science Center at San Antonio, San Antonio, Texas 78229 3900, USA
    J Child Adolesc Psychopharmacol 18:565-71. 2008
  5. pmc Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression?
    W Burleson Daviss
    Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    J Child Adolesc Psychopharmacol 18:257-64. 2008
  6. ncbi request reprint Steady-state pharmacokinetics of bupropion SR in juvenile patients
    W Burleson Daviss
    Western Psychiatric Institute and Clinic, University of Pittsburgh, 3811 O Hara Street, Pittsburgh, PA 15213, USA
    J Am Acad Child Adolesc Psychiatry 44:349-57. 2005
  7. ncbi request reprint Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study
    W Burleson Daviss
    Western Psychiatric Institute and Clinic, Pittsburgh, PA, and the University of Pittsburgh, Pittsburgh, PA 15213, USA
    Ther Drug Monit 28:190-8. 2006
  8. pmc Differentiating major depressive disorder in youths with attention deficit hyperactivity disorder
    Rasim Somer Diler
    Division of Child Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA
    J Affect Disord 102:125-30. 2007
  9. doi request reprint Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis
    W Burleson Daviss
    University of Texas Health Science Center at San Antonio, TX, USA
    J Am Acad Child Adolesc Psychiatry 47:189-98. 2008
  10. ncbi request reprint A chart review of cyproheptadine for stimulant-induced weight loss
    W Burleson Daviss
    Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA
    J Child Adolesc Psychopharmacol 14:65-73. 2004

Research Grants

Detail Information

Publications11

  1. doi request reprint Associations of lifetime depression with trauma exposure, other environmental adversities, and impairment in adolescents with ADHD
    W Burleson Daviss
    Department of Psychiatry, University of Texas Health Science Center of San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Abnorm Child Psychol 37:857-71. 2009
    ....
  2. ncbi request reprint Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects
    W Burleson Daviss
    Western Psychiatric Institute and Clinic and the University of Pittsburgh, USA
    J Child Psychol Psychiatry 47:927-34. 2006
    ..The current study re-examines the criterion validity of child- and parent-versions of the Mood and Feelings Questionnaire (MFQ-C, MFQ-P) in a heterogeneous sample of children and adolescents from clinic and non-clinic sources...
  3. ncbi request reprint Steady-state clinical pharmacokinetics of bupropion extended-release in youths
    W Burleson Daviss
    Western Psychiatric Institute and Clinic, University of Pittsburgh, USA
    J Am Acad Child Adolesc Psychiatry 45:1503-9. 2006
    ..To examine in children and adolescents the 24-hour, steady-state clinical pharmacokinetics of an extended-release (XL) formulation of bupropion (Wellbutrin XL)...
  4. pmc A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment
    W Burleson Daviss
    Deparment of Psychiatry, University of Texas Science Center at San Antonio, San Antonio, Texas 78229 3900, USA
    J Child Adolesc Psychopharmacol 18:565-71. 2008
    ..There is also some indirect evidence for the benefit of combining pharmacological treatments with psychosocial interventions that specifically target relevant environmental factors and functional impairments...
  5. pmc Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression?
    W Burleson Daviss
    Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    J Child Adolesc Psychopharmacol 18:257-64. 2008
    ....
  6. ncbi request reprint Steady-state pharmacokinetics of bupropion SR in juvenile patients
    W Burleson Daviss
    Western Psychiatric Institute and Clinic, University of Pittsburgh, 3811 O Hara Street, Pittsburgh, PA 15213, USA
    J Am Acad Child Adolesc Psychiatry 44:349-57. 2005
    ..To examine the steady-state pharmacokinetic properties of bupropion sustained release (SR) and their potential developmental differences in youths...
  7. ncbi request reprint Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study
    W Burleson Daviss
    Western Psychiatric Institute and Clinic, Pittsburgh, PA, and the University of Pittsburgh, Pittsburgh, PA 15213, USA
    Ther Drug Monit 28:190-8. 2006
    ..009). These preliminary findings suggest that plasma levels of bupropion and metabolites, particularly hydroxybupropion, may predict acute antidepressant response in depressed youths taking bupropion SR...
  8. pmc Differentiating major depressive disorder in youths with attention deficit hyperactivity disorder
    Rasim Somer Diler
    Division of Child Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA
    J Affect Disord 102:125-30. 2007
    ..Our objective was to examine which depressive symptoms best discriminate MDD among youths with ADHD...
  9. doi request reprint Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis
    W Burleson Daviss
    University of Texas Health Science Center at San Antonio, TX, USA
    J Am Acad Child Adolesc Psychiatry 47:189-98. 2008
    ..To examine the safety and tolerability of clonidine used alone or with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD)...
  10. ncbi request reprint A chart review of cyproheptadine for stimulant-induced weight loss
    W Burleson Daviss
    Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA
    J Child Adolesc Psychopharmacol 14:65-73. 2004
    ..We conclude that concomitant cyproheptadine may be useful in youths with attention deficit hyperactivity disorder for stimulant-induced weight loss, pending future randomized controlled trials...
  11. doi request reprint Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes
    Donna R Palumbo
    University of Rochester, USA
    J Am Acad Child Adolesc Psychiatry 47:180-8. 2008
    ..To determine the efficacy and safety of clonidine, used alone or in combination with methylphenidate, in treating attention-deficit/hyperactivity disorder (ADHD)...

Research Grants2

  1. Bupropion in Adolescents with Comorbid ADHD & Depression
    WILLIAM DAVISS; Fiscal Year: 2007
    ..The candidate' s training and research experiences during the RCDA will enable him to pursue larger, more scientifically rigorous pharmacologic trials of youth with ADHD and depressive or other comorbid psychopathology. ..